Apellis Pharmaceuticals, Inc. vs ABBOTT LABORATORIES, risk disclosures compared

5topics both disclose

5only Apellis Pharmaceuticals, Inc.

1only ABBOTT LABORATORIES

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	Apellis Pharmaceuticals, Inc.	ABBOTT LABORATORIES
Material Weakness	8	1
Internal Control	5	3
Business Continuity	1	4
Consent Order	3	1
Artificial Intelligence	1	1

Only Apellis Pharmaceuticals, Inc.

Topic	Filings
Privacy Compliance	4
Ransomware	4
Regulatory Investigation	2
Records Retention	1
Restatement	1

Only ABBOTT LABORATORIES

Topic	Filings
Data Breach	1

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

Apellis Pharmaceuticals, Inc. · ABBOTT LABORATORIES · All companies